Welcome to LookChem.com Sign In|Join Free

CAS

  • or

92197-36-9

Post Buying Request

92197-36-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

92197-36-9 Usage

Chemical class

Piperidine derivatives
BHMP is a compound that belongs to the class of piperidine derivatives, which are organic compounds containing a six-membered nitrogen-containing ring.
2. Pharmaceutical intermediate
1-Benzyl-4-hydroxyMethylpiperidin-4-ol is commonly used as a pharmaceutical intermediate, meaning it is a substance used in the synthesis of various medications.
3. Molecular structure

Piperidine ring

BHMP has a piperidine ring structure, which is a six-membered nitrogen-containing ring.

Benzyl group

A benzyl group is attached to the piperidine ring, which is a phenyl group connected to a methyl group.

Hydroxymethyl group

A hydroxymethyl group is also attached to the piperidine ring, which is a methyl group connected to a hydroxyl group (-OH).
4. Antioxidant potential
BHMP has been studied for its potential use as an antioxidant, which means it may help neutralize harmful free radicals in the body and protect cells from damage.
5. Inhibition of harmful free radicals
The compound has shown promise in inhibiting the formation of harmful free radicals, which can contribute to various diseases and aging processes.
6. Neurodegenerative disease treatment
1-Benzyl-4-hydroxyMethylpiperidin-4-ol has demonstrated potential in the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's, by potentially protecting neurons from damage and degeneration.
7. Anti-inflammatory properties
BHMP has also shown promise as an anti-inflammatory agent, which means it may help reduce inflammation and swelling in the body, potentially providing relief from various inflammatory conditions.
8. Ongoing research
1-Benzyl-4-hydroxyMethylpiperidin-4-ol continues to be an active area of research due to its potential pharmacological properties and potential application in various therapeutic areas.

Check Digit Verification of cas no

The CAS Registry Mumber 92197-36-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,2,1,9 and 7 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 92197-36:
(7*9)+(6*2)+(5*1)+(4*9)+(3*7)+(2*3)+(1*6)=149
149 % 10 = 9
So 92197-36-9 is a valid CAS Registry Number.

92197-36-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-benzyl-4-(hydroxymethyl)piperidin-4-ol

1.2 Other means of identification

Product number -
Other names 1-benzyl-4-hydroxymethyl-piperidin-4-ol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:92197-36-9 SDS

92197-36-9Relevant articles and documents

HEPATITIS B ANTIVIRAL AGENTS

-

Page/Page column 194, (2013/07/05)

The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

-

Page/Page column 26-27, (2010/02/14)

The present invention relates to alkyne compounds of general formula I wherein the groups and radicals A, B, W, X, Y, Z, R1 and R2 have the meanings given in claim 1. Moreover the invention relates to pharmaceutical compositions containing at least one alkyne according to the invention. By virtue of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity and diabetes.

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

-

Page/Page column 24, (2010/02/14)

Alkyne compounds of formula I wherein A, B, W, X, Y, Z, R1, and R2 have the meanings given herein, which have MCH-receptor antagonistic activity and are useful for preparing pharmaceutical compositions for the treatment of metabolic disorders and/or eating disorders, particularly obesity and diabetes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 92197-36-9